Jane Street Group, LLC Coh Bar, Inc. Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$0.17 - $0.34 $2,678 - $5,357	15,757 Added 140.78%	26,950 $5,000
Q1 2022 May 17, 2022	BUY	$0.25 - $0.43 $2,798 - $4,812	11,193 New	11,193 $4,000
Q1 2021 May 18, 2021	SELL	$1.26 - $2.02 $20,398 - $32,701	-16,189 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$0.9 - $1.54 $14,570 - $24,931	16,189 New	16,189 $22,000
Q3 2020 Nov 17, 2020	SELL	$0.87 - $2.08 $32,993 - $78,881	-37,924 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$1.08 - $4.0 $40,957 - $151,696	37,924 New	37,924 $58,000
Q3 2019 Nov 14, 2019	SELL	$1.3 - $1.76 $33,659 - $45,569	-25,892 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$1.63 - $3.3 $42,203 - $85,443	25,892 New	25,892 $45,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.57M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.